Smithsonian Institution and Varsity Tutors Team Up for a Free Paleontology Class for Learners Around the World
“Live from the Smithsonian: Living in the World of Dinosaurs” Class Provides Inside Access to…
“Live from the Smithsonian: Living in the World of Dinosaurs” Class Provides Inside Access to…
BOSTON, May 20, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that…
WINSTON-SALEM, N.C., May 20, 2022 (GLOBE NEWSWIRE) — ProKidney LP (ProKidney), a leading clinical-stage cellular…
Further Expands Board’s Expertise and Gender Diversity Enhances Corporate Governance BOSTON, May 20, 2022 (GLOBE…
HALIFAX, Nova Scotia, May 20, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold…
Positive opinion could expand the role of Cosentyx® (secukinumab) in reducing flare risk in pediatric…
JERSEY CITY, N.J., May 20, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
JUPITER, Fla., May 20, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
VAZALORE Featured in Prominent Publication as Promising Alternative to Current Aspirin Options for Secondary Prevention…
YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late…
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
GAITHERSBURG, Md., May 20, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
WATERTOWN, Mass., May 20, 2022 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ET…
– PTR-01 was well-tolerated over a four-month treatment period in RDEB patients – Treatment with…
MENLO PARK, Calif. and SINGAPORE, May 20, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN),…
NEW HAVEN, Conn., May 20, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) — Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company…
For all our customers. To show the love. Pay just $35/line per month for four…